Therapeutic Monoclonal Antibodies - From Lot Release to Stability Testing | Agenda Bookshop Skip to content
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
A01=Harleen Kaur
Age Group_Uncategorized
Age Group_Uncategorized
Author_Harleen Kaur
automatic-update
Category1=Non-Fiction
Category=MMG
Category=TCB
COP=United Kingdom
Delivery_Pre-order
Language_English
PA=Not yet available
Price_€100 and above
PS=Forthcoming
softlaunch

Therapeutic Monoclonal Antibodies - From Lot Release to Stability Testing

English

By (author): Harleen Kaur

Therapeutic Monoclonal Antibodies: From Lot Release to Stability Testing is a highly topical resource on a subject of interest for scientists and researchers working on monoclonal antibodies' characterization, release testing, stability testing and similarity assessments of monoclonal antibodies in the biopharmaceutical industry. Monoclonal antibodies (mAbs) are large, extremely complex and dynamic biomolecules, so it can be challenging to develop well-characterized therapeutic antibodies that meet regulatory expectations that are also in-line with commercialized standards for different drug markets. Lot release testing and understanding the stability of the mAb over a period of time, and in different environmental conditions, is an indispensable aspect of mAb physicochemical characterization. This book covers the process, including extensive analysis that starts with quantifying the purity attribute to glycan profiling and identifying the mAb primary structure. The book has a primary purpose of focusing on both Lot release testing and stability testing of monoclonal antibodies (subjects not covered in any great detail in other books). See more
Current price €122.54
Original price €128.99
Save 5%
A01=Harleen KaurAge Group_UncategorizedAuthor_Harleen Kaurautomatic-updateCategory1=Non-FictionCategory=MMGCategory=TCBCOP=United KingdomDelivery_Pre-orderLanguage_EnglishPA=Not yet availablePrice_€100 and abovePS=Forthcomingsoftlaunch

Will deliver when available. Publication date 15 Jun 2024

Product Details
  • Dimensions: 151 x 229mm
  • Publication Date: 15 Jun 2024
  • Publisher: Elsevier Science & Technology
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9780323906005

About Harleen Kaur

Harleen Kaur PhD is affiliated with Aurobindo Pharma Ltd. in the Biologics Division based in Hyderabad India. Dr Kaur is the lead editor of Monoclonal Antibodies: Physicochemical Analysis. Her research focuses on the analytical development and characterization of large molecules particularly mAbs and on bringing therapeutic products from early discovery to commercial launch. Previously she has worked for AstraZeneca both in the United States and India and has extensive experience in technology transfer and development of biologics in a highly regulated environment. She earned her undergraduate degree from Guru Gobind Singh Indraprastha University Delhi India and PhD degree from the National University of Singapore Singapore. She is the author of many peer-reviewed publications and book chapters in the area of antibody characterization and aptamers.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept